We are live on ! Find out more
AZN icon

AstraZeneca

546 hedge funds and large institutions have $17.4B invested in AstraZeneca in 2018 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 150 increasing their positions, 197 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $225M | Put options by funds: $73.5M

114% more capital inflows, than outflows

Capital inflows: $2.17B | Capital outflows: $1.02B

40% more first-time investments, than exits

New positions opened: 66 | Existing positions closed: 47

3% more funds holding

Funds holding: 531 → 546 (+15)

0.98% more ownership

Funds ownership: 13.16% → 14.14% (+0.98%)

24% less repeat investments, than reductions

Existing positions increased: 150 | Existing positions reduced: 197

40% less funds holding in top 10

Funds holding in top 10: 5 → 3 (-2)

Holders
546
Holders Change
+15
Holders Change %
+2.82%
% of All Funds
12.43%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
66
Increased
150
Reduced
197
Closed
47
Calls
$225​M
Puts
$73.5​M
Net Calls
+$152​M
Net Calls Change
+$45​M

AZN Hedge Fund Activity: Q3 2018 in Review

546 of the 4,393 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZN) for Q3 2018, worth a combined $17.4B — up 21% from $14.3B a quarter earlier.

Buyers outnumbered sellers: 66 funds opened new AZN positions and 47 closed out — a net gain of 19 holders — while 150 added to existing stakes and 197 trimmed.

The largest buyer was Jennison Associates, adding an estimated $774M. The largest seller was Bank of America, cutting an estimated $123M.

  • 546 institutional investors held AstraZeneca (AZN) as of Q3 2018, up from 531 in Q2 2018.
  • Funds reported $17.4B of AstraZeneca stock for Q3 2018, up 21% quarter-over-quarter.
  • 66 funds opened new AstraZeneca positions in Q3 2018 and 47 closed out, a net change of +19 holders.
  • The largest AstraZeneca buyer in Q3 2018 was Jennison Associates, an estimated $774M added.
  • The largest AstraZeneca seller in Q3 2018 was Bank of America, an estimated $123M sold.

Based on aggregated 13F filings for Q3 2018.